These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7724833)

  • 1. Interspecies extrapolation in safety evaluation of human medicines in The Netherlands (1990-1992): practical considerations.
    Peters-Volleberg GW; De Waal EJ; Van der Laan JW
    Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 1):248-58. PubMed ID: 7724833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapolation of animal toxicity data to man.
    Vocci F; Farber T
    Regul Toxicol Pharmacol; 1988 Dec; 8(4):389-98. PubMed ID: 3222480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals.
    Reichard JF; Maier MA; Naumann BD; Pecquet AM; Pfister T; Sandhu R; Sargent EV; Streeter AJ; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S67-78. PubMed ID: 27224509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data derived extrapolation factors (DDEFs) for rat to human interspecies extrapolation for the HPPD inhibitor mesotrione.
    Pecquet AM; Bridgwood K; Cowie D; Hofstra A; Wu Y; Whalley S; Webb SD
    Crit Rev Toxicol; 2024 Jul; 54(6):418-429. PubMed ID: 38869005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between pharmacokinetics and toxicokinetics.
    Welling PG
    Toxicol Pathol; 1995; 23(2):143-7. PubMed ID: 7569668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective.
    Gundert-Remy U; Sonich-Mullin C;
    Sci Total Environ; 2002 Apr; 288(1-2):3-11. PubMed ID: 12013545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the dog in toxicity tests on pharmaceutical compounds.
    Parkinson C; Grasso P
    Hum Exp Toxicol; 1993 Mar; 12(2):99-109. PubMed ID: 8096722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapolation of animal toxicity to humans: interspecies comparisons in drug development.
    Voisin EM; Ruthsatz M; Collins JM; Hoyle PC
    Regul Toxicol Pharmacol; 1990 Oct; 12(2):107-16. PubMed ID: 2259752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicokinetic Model Development for the Insensitive Munitions Component 3-Nitro-1,2,4-Triazol-5-One.
    Sweeney LM; Phillips EA; Goodwin MR; Bannon DI
    Int J Toxicol; 2015; 34(5):408-16. PubMed ID: 26060267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To what extent can results of experimental studies be extrapolated in predicting adverse side effects of drugs in man?
    Grimová J; Roubal Z; Dlabac A
    Arch Toxicol Suppl; 1986; 9():240-3. PubMed ID: 3468902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation.
    Dorne JL
    Fundam Clin Pharmacol; 2004 Dec; 18(6):609-20. PubMed ID: 15548231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The registration of medicines in The Netherlands.
    Drost RA; Reijnders PJ
    J Clin Pharmacol; 1987 Dec; 27(12):937-44. PubMed ID: 3437065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distributions for time, interspecies and intraspecies extrapolation for deriving occupational exposure limits.
    Dilger M; Schneider K; Drossard C; Ott H; Kaiser E
    J Appl Toxicol; 2022 May; 42(5):898-912. PubMed ID: 35187686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
    Bokkers BG; Slob W
    Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety assessments of chemicals with thresholded effects.
    Lu FC
    Regul Toxicol Pharmacol; 1985 Dec; 5(4):460-4. PubMed ID: 4095286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapolation of pharmacological and toxicological data based on metabolic weight.
    Van Miert AS
    Arch Exp Veterinarmed; 1989; 43(4):481-8. PubMed ID: 2695001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generics: what is the role of registration authorities.
    Versantvoort C; Maliepaard M; Lekkerkerker F
    Neth J Med; 2008 Feb; 66(2):62-6. PubMed ID: 18292608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems in extrapolating toxicity data for laboratory animals to man.
    Dixon RL
    Environ Health Perspect; 1976 Feb; 13():43-50. PubMed ID: 817897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-animal approaches for toxicokinetics in risk evaluations of food chemicals.
    Punt A; Peijnenburg AACM; Hoogenboom RLAP; Bouwmeester H
    ALTEX; 2017; 34(4):501-514. PubMed ID: 28403478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.